Clinical Trial Update: Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) [Phase 3]

View source ↗

Summary

Phase 3 trial update for a biosimilar erythropoietin in renal anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• biosimilar erythropoietin

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Renal Anemia | Phase 3 | Status: COMPLETED